Evolent Health (EVH) Tops Q3 EPS by 50c

Evolent Health (NYSE: EVH) reported Q3 EPS of $0.62, $0.50 better than the analyst estimate of $0.12. Revenue for the quarter came in at $352.6 million versus the consensus estimate of $357.32 million.

For earnings history and earnings-related data on Evolent Health (EVH) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Prosperity Bancshares (PB) Reiterated at Overweight by Cantor Fitzgerald as Estimates Revised
• RBC Capital Starts Molina Healthcare (MOH) at Sector Perform